Characterization of [3H]U46619 binding in pig aorta smooth muscle membranes

This publication has 20 references indexed in Scilit:

• Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)
  Thrombosis Research, 1986
• Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
  Proceedings of the National Academy of Sciences, 1985
• A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand
  Biochemical Pharmacology, 1985
• Competitive antagonism at thromboxane receptors in human platelets
  British Journal of Pharmacology, 1985
• Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs
  Biochemical Pharmacology, 1985
• Ligand binding to thromboxane receptors on human platelets: correlation with biological activity
  British Journal of Pharmacology, 1983
• Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues
  British Journal of Pharmacology, 1983
• Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1983
• ANTAGONISM OF THE THROMBOXANE‐SENSITIVE CONTRACTILE SYSTEMS OF THE RABBIT AORTA, DOG SAPHENOUS VEIN AND GUINEA‐PIG TRACHEA
  British Journal of Pharmacology, 1982
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973